2/16/2007 | CVHY | Pharmacopeia Drug Discovery files $45 million shelf
|
11/2/2006 | BT | Pharmacopeia's cash position up slightly at $31 million
|
10/16/2006 | PP | Market Commentary: Vical settles $12.55 million direct stock sale; Watch Resources plans C$18 million PIPE
|
10/13/2006 | BT | Market Commentary: Critical gains 5% on sale signals; Advancis warns, eyes new deal; Pharmacopeia rises 4% on PIPE
|
10/13/2006 | PP | Market Commentary: Pharmacopeia stock climbs on $24.8 million stock sale; flow-through offerings strong in Canada
|
10/13/2006 | BTPP | New Issue: Pharmacopeia secures $24.82 million from placement of stock
|
9/29/2006 | BT | Market Commentary: Exelixis follow-on set for Oct. 2 week; ImaRx on tap; Biomira bounces; Labopharm, Pharmacopeia lower
|
9/28/2006 | BT | Pharmacopeia extends agreement with Schering-Plough
|
9/19/2006 | BT | Pharmacopeia triggers milestone payment from Organon
|
9/18/2006 | BT | Pharmacopeia to focus on developing portfolio, maintaining compounds longer
|
9/11/2006 | BT | Pharmacopeia earns milestone from Schering-Plough
|
6/2/2006 | BTCV | Pharmacopeia Drug Discovery files $35 million shelf
|
5/23/2006 | BT | Pharmacopeia, Cephalon to develop new therapeutic products
|
4/17/2006 | BT | Pharmacopeia, Schering-Plough identify novel therapeutic candidate for metabolic disease
|
4/11/2006 | BT | Pharmacopeia discovers new respiratory disease therapy, gets milestone payment
|
4/3/2006 | BT | Pharmacopeia licenses novel therapeutic candidates from Bristol-Myers Squibb
|
3/30/2006 | BT | GlaxoSmithKline, Pharmacopeia to collaborate on drug discovery
|
3/15/2006 | BT | Pharmacopeia, Neurocrine expand drug discovery, development collaboration
|
2/22/2006 | BT | Pharmacopeia, Biovitrum discover new class of compounds, advance development
|
2/8/2006 | BT | Pharmacopeia delivers compounds to Celgene, triggers milestone payment
|
1/17/2006 | BT | Pharmacopeia, Bristol-Myers advance rheumatoid arthritis candidate phase 1 trial
|
1/11/2006 | BT | Pharmacopeia gets milestone payment from Organon
|
12/1/2005 | BT | Schering-Plough cancels trials on respiratory indications for a Pharmacopeia-collaborated drug
|
7/28/2005 | BTPP | New Issue: Pharmacopeia prices $8.47 million private placement of stock
|